At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Motherwell +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial
In Brief
A clinical study evaluating Motherwell and Placebo for Postpartum Blues and Healthy. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood in postpartum as compared to placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostpartum Blues, Healthy
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartDec 2018
Primary CompletionDec 2022
Study CompletionJun 2023
TodayJul 2026
First PostedSep 29, 2017
Enrollment StartDec 1, 2018
Primary CompletionDec 25, 2022
Study CompletionJun 20, 2023
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 8.8 years ago
Interventions
Motherwelldietary
The interventions involves a dietary supplement called Motherwell, at current stage, to reduce the intensity of sadness in day-5 postpartum women.
Placeboother
Matching placebo for appearance, taste